Deignan, J. L., Chung, W. K., Kearney, H. M., Monaghan, K. G., Rehder, C. W., Chao, E. C., & ACMG Laboratory Quality AssuranceCommittee, . (2019). Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med, 21(6), 1267–1270. https://doi.org/10.1038/s41436-019-0478-1

Deignan, Joshua L., Wendy K. Chung, Hutton M. Kearney, Kristin G. Monaghan, Catherine W. Rehder, Elizabeth C. Chao, and Elizabeth C. ACMG Laboratory Quality AssuranceCommittee. “Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG).” Genet Med 21, no. 6 (June 2019): 1267–70. https://doi.org/10.1038/s41436-019-0478-1.

Deignan JL, Chung WK, Kearney HM, Monaghan KG, Rehder CW, Chao EC, et al. Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2019 Jun;21(6):1267–70.

Deignan, Joshua L., et al. “Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG).” Genet Med, vol. 21, no. 6, June 2019, pp. 1267–70. Pubmed, doi:10.1038/s41436-019-0478-1.

Deignan JL, Chung WK, Kearney HM, Monaghan KG, Rehder CW, Chao EC, ACMG Laboratory Quality AssuranceCommittee. Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2019 Jun;21(6):1267–1270.